Logo image of LFMD

LIFEMD INC (LFMD) Stock Fundamental Analysis

NASDAQ:LFMD - Nasdaq - US53216B1044 - Common Stock - Currency: USD

5.46  -2.06 (-27.39%)

After market: 5.5094 +0.05 (+0.9%)

Fundamental Rating

3

Overall LFMD gets a fundamental rating of 3 out of 10. We evaluated LFMD against 39 industry peers in the Health Care Technology industry. Both the profitability and financial health of LFMD have multiple concerns. LFMD shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

LFMD had negative earnings in the past year.
LFMD had a positive operating cash flow in the past year.
LFMD had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LFMD reported negative operating cash flow in multiple years.
LFMD Yearly Net Income VS EBIT VS OCF VS FCFLFMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -35.30%, LFMD perfoms like the industry average, outperforming 43.24% of the companies in the same industry.
Industry RankSector Rank
ROA -35.3%
ROE N/A
ROIC N/A
ROA(3y)-117.88%
ROA(5y)-183.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LFMD Yearly ROA, ROE, ROICLFMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5K -10K -15K

1.3 Margins

LFMD's Gross Margin of 89.64% is amongst the best of the industry. LFMD outperforms 94.59% of its industry peers.
LFMD's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for LFMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.79%
GM growth 5Y2.59%
LFMD Yearly Profit, Operating, Gross MarginsLFMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMD has more shares outstanding
Compared to 5 years ago, LFMD has more shares outstanding
Compared to 1 year ago, LFMD has a worse debt to assets ratio.
LFMD Yearly Shares OutstandingLFMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
LFMD Yearly Total Debt VS Total AssetsLFMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -0.50, we must say that LFMD is in the distress zone and has some risk of bankruptcy.
LFMD has a Altman-Z score (-0.50) which is in line with its industry peers.
LFMD has a debt to FCF ratio of 1.72. This is a very positive value and a sign of high solvency as it would only need 1.72 years to pay back of all of its debts.
The Debt to FCF ratio of LFMD (1.72) is better than 75.68% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.72
Altman-Z -0.5
ROIC/WACCN/A
WACC10.62%
LFMD Yearly LT Debt VS Equity VS FCFLFMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

A Current Ratio of 0.83 indicates that LFMD may have some problems paying its short term obligations.
LFMD has a Current ratio of 0.83. This is in the lower half of the industry: LFMD underperforms 75.68% of its industry peers.
A Quick Ratio of 0.78 indicates that LFMD may have some problems paying its short term obligations.
With a Quick ratio value of 0.78, LFMD is not doing good in the industry: 75.68% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.78
LFMD Yearly Current Assets VS Current LiabilitesLFMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

7

3. Growth

3.1 Past

LFMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.69%, which is quite impressive.
Looking at the last year, LFMD shows a very strong growth in Revenue. The Revenue has grown by 42.15%.
LFMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 79.00% yearly.
EPS 1Y (TTM)34.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)42.15%
Revenue growth 3Y59.92%
Revenue growth 5Y79%
Sales Q2Q%38.28%

3.2 Future

Based on estimates for the next years, LFMD will show a very strong growth in Earnings Per Share. The EPS will grow by 32.61% on average per year.
LFMD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.23% yearly.
EPS Next Y19.44%
EPS Next 2Y39.35%
EPS Next 3Y31.7%
EPS Next 5Y32.61%
Revenue Next Year38.86%
Revenue Next 2Y31.79%
Revenue Next 3Y26.74%
Revenue Next 5Y28.23%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LFMD Yearly Revenue VS EstimatesLFMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
LFMD Yearly EPS VS EstimatesLFMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

LFMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LFMD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFMD Price Earnings VS Forward Price EarningsLFMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

LFMD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. LFMD is cheaper than 72.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.25
EV/EBITDA N/A
LFMD Per share dataLFMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

LFMD's earnings are expected to grow with 31.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.35%
EPS Next 3Y31.7%

More info and screens

0

5. Dividend

5.1 Amount

LFMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIFEMD INC

NASDAQ:LFMD (2/21/2025, 8:00:02 PM)

After market: 5.5094 +0.05 (+0.9%)

5.46

-2.06 (-27.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-10 2025-03-10/amc
Inst Owners37.55%
Inst Owner Change-7.6%
Ins Owners15.43%
Ins Owner Change3.34%
Market Cap236.47M
Analysts81.33
Price Target11.96 (119.05%)
Short Float %13.37%
Short Ratio6.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.09
Dividend Growth(5Y)N/A
DP-12.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.34%
Min EPS beat(2)-49.02%
Max EPS beat(2)-15.66%
EPS beat(4)1
Avg EPS beat(4)-17.42%
Min EPS beat(4)-49.02%
Max EPS beat(4)15.97%
EPS beat(8)2
Avg EPS beat(8)-40.52%
EPS beat(12)3
Avg EPS beat(12)-33.85%
EPS beat(16)5
Avg EPS beat(16)-81.42%
Revenue beat(2)1
Avg Revenue beat(2)0.12%
Min Revenue beat(2)-2.71%
Max Revenue beat(2)2.94%
Revenue beat(4)3
Avg Revenue beat(4)2.65%
Min Revenue beat(4)-2.71%
Max Revenue beat(4)8.61%
Revenue beat(8)5
Avg Revenue beat(8)-0.32%
Revenue beat(12)5
Avg Revenue beat(12)-2.02%
Revenue beat(16)5
Avg Revenue beat(16)-2.35%
PT rev (1m)-2.31%
PT rev (3m)-6.76%
EPS NQ rev (1m)-16.89%
EPS NQ rev (3m)-15.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.31%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)0.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.22
P/FCF 22.25
P/OCF 10.92
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.25
FCFY4.49%
OCF(TTM)0.5
OCFY9.16%
SpS4.46
BVpS-0.18
TBVpS-0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.3%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.64%
FCFM 5.51%
ROA(3y)-117.88%
ROA(5y)-183.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.79%
GM growth 5Y2.59%
F-Score6
Asset Turnover2.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.72
Debt/EBITDA N/A
Cap/Depr 124.1%
Cap/Sales 5.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.78
Altman-Z -0.5
F-Score6
WACC10.62%
ROIC/WACCN/A
Cap/Depr(3y)251.46%
Cap/Depr(5y)170.88%
Cap/Sales(3y)5.58%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y19.44%
EPS Next 2Y39.35%
EPS Next 3Y31.7%
EPS Next 5Y32.61%
Revenue 1Y (TTM)42.15%
Revenue growth 3Y59.92%
Revenue growth 5Y79%
Sales Q2Q%38.28%
Revenue Next Year38.86%
Revenue Next 2Y31.79%
Revenue Next 3Y26.74%
Revenue Next 5Y28.23%
EBIT growth 1Y-37.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year187.06%
EBIT Next 3Y67.15%
EBIT Next 5Y59.57%
FCF growth 1Y129.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.8%
OCF growth 3YN/A
OCF growth 5YN/A